Clinical Outcomes of Comparison Between Type III Coronary Artery Perforation (CAP) and non-CAP Acute Coronary Syndrome Patients During 3-Year Follow-up

Basit Öğe Kaydı
dc.authorscopusid55149809000
dc.authorscopusid57190382986
dc.authorscopusid57199652078
dc.authorscopusid55711129400
dc.authorscopusid57202391627
dc.contributor.authorYıldız, Bekir S.
dc.contributor.authorGündüz, Ramazan
dc.contributor.authorÖzgur, Su
dc.contributor.authorÇizgici, Ahmet Y.
dc.contributor.authorÖzdemir, İbrahim H.
dc.date.accessioned2024-08-25T18:31:31Z
dc.date.available2024-08-25T18:31:31Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractCoronary artery perforation (CAP) is a potentially fatal complication of percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS). This study aimed to investigate in-hospital, 1-year, and 3-year clinical outcomes of type III CAP during PCI in patients with ACS. The study retrospectively evaluated 118 patients with CAP and 43,226 case-control patients. Clinical, angiographic, and procedural characteristics, management, and outcomes were analyzed retrospectively at 1-year and 3-year follow-ups. The mean age of the patients was 66.5 +/- 11.9 years (61.8% males). There was no significant difference in hospital mortality between the type III CAP and non-CAP groups. The all-cause mortality was 33.3% in the CAP group vs 1.8% in the non-CAP group at 1 year, and 28.3% in CAP group vs 6.9% in non-CAP group at 3 years (p < .001 for both comparisons). The procedural, clinical, and 1 and 3-year outcomes of type III CAP showed a relatively high risk of myocardial infarction, coronary artery bypass graft, cerebrovascular event, stent thrombosis, and major bleeding at the 1 and 3-year follow-ups. In addition, non-CAP ACS patients had better survival (log-rank: p <.001, 34.29 months 95% Confidence Interval [33.58-35.00]) than type III CAP ACS patients (29.53 months 95% Confidence Interval [27.28-31.78]) at the 3-year follow-up visit.en_US
dc.identifier.doi10.1177/00033197231200029
dc.identifier.issn0003-3197
dc.identifier.issn1940-1574
dc.identifier.pmid37694576en_US
dc.identifier.scopus2-s2.0-85170851755en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1177/00033197231200029
dc.identifier.urihttps://hdl.handle.net/11454/99923
dc.identifier.wosWOS:001066789100001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSage Publications Incen_US
dc.relation.ispartofAngiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240825_Gen_US
dc.subjectacute coronary syndromeen_US
dc.subjectcoronary artery perforationen_US
dc.subject3-year follow-upen_US
dc.subjectPolytetrafluoroethylene-Covered Stenten_US
dc.subjectSaphenous-Vein Graftsen_US
dc.subjectMyocardial-Infarctionen_US
dc.subjectRisk Stratificationen_US
dc.subjectUnstable Anginaen_US
dc.subjectManagementen_US
dc.subjectInterventionen_US
dc.subjectImplantationen_US
dc.subjectDefinitionen_US
dc.subjectPredictorsen_US
dc.titleClinical Outcomes of Comparison Between Type III Coronary Artery Perforation (CAP) and non-CAP Acute Coronary Syndrome Patients During 3-Year Follow-upen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu